SEGMENT INFORMATION - Summary of Financial Information for Our Segments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Segment Reporting Information [Line Items]
Net sales	$ 2,835	$ 2,699	$ 8,270	$ 7,883
United States
Segment Reporting Information [Line Items]
Net sales	1,544	1,500	4,570	4,340
International
Segment Reporting Information [Line Items]
Net sales	1,291	1,199	3,700	3,543
Operating Segments | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	1,329	1,342	3,911	3,893
Operating Segments | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	773	752	2,244	2,167
Operating Segments | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	632	588	1,825	1,768
Operating Segments | United States | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	723	762	2,164	2,164
Operating Segments | United States | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	577	557	1,657	1,580
Operating Segments | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	177	178	559	566
Operating Segments | International | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	606	580	1,747	1,729
Operating Segments | International | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	196	195	587	587
Operating Segments | International | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	455	410	1,266	1,202
Operating Segments | Infusion Therapies & Technologies | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	1,023	1,070	3,041	3,081
Operating Segments | Infusion Therapies & Technologies | United States | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	555	613	1,693	1,718
Operating Segments | Infusion Therapies & Technologies | International | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	468	457	1,348	1,363
Operating Segments | Advanced Surgery | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	306	272	870	812
Operating Segments | Advanced Surgery | United States | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	168	149	471	446
Operating Segments | Advanced Surgery | International | Medical Products & Therapies
Segment Reporting Information [Line Items]
Net sales	138	123	399	366
Operating Segments | Care & Connectivity Solutions | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	473	456	1,374	1,310
Operating Segments | Care & Connectivity Solutions | United States | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	348	335	1,005	945
Operating Segments | Care & Connectivity Solutions | International | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	125	121	369	365
Operating Segments | Front Line Care | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	300	296	870	857
Operating Segments | Front Line Care | United States | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	229	222	652	635
Operating Segments | Front Line Care | International | Healthcare Systems & Technologies
Segment Reporting Information [Line Items]
Net sales	71	74	218	222
Operating Segments | Injectables & Anesthesia | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	333	321	1,000	990
Operating Segments | Injectables & Anesthesia | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	177	178	559	566
Operating Segments | Injectables & Anesthesia | International | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	156	143	441	424
Operating Segments | Drug Compounding | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	299	267	825	778
Operating Segments | Drug Compounding | United States | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Operating Segments | Drug Compounding | International | Pharmaceuticals
Segment Reporting Information [Line Items]
Net sales	299	267	825	778
Other
Segment Reporting Information [Line Items]
Net sales	101	17	290	55
Other | United States
Segment Reporting Information [Line Items]
Net sales	67	3	190	30
Other | International
Segment Reporting Information [Line Items]
Net sales	$ 34	$ 14	$ 100	$ 25